ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tatva Chintan Pharma Chem's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹413 Mil.
Tatva Chintan Pharma Chem's average Total Assets over the quarter that ended in Mar. 2026 was ₹10,037 Mil. Therefore, Tatva Chintan Pharma Chem's annualized ROA % for the quarter that ended in Mar. 2026 was 4.11%.
The historical rank and industry rank for Tatva Chintan Pharma Chem's ROA % or its related term are showing as below:
NSE:TATVA'
s ROA % Range Over the Past 10 Years
Min: 0.69 Med: 8.69 Max: 19.71
Current: 4.59
During the past 8 years, Tatva Chintan Pharma Chem's highest ROA % was 19.71%. The lowest was 0.69%. And the median was 8.69%.
NSE:TATVA's ROA % is ranked better than 64.43% of 1608
companies
in the Chemicals industry
Industry Median: 2.9
vs NSE:TATVA: 4.59
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem ROA % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's ROA % distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Tatva Chintan Pharma Chem (NSE:TATVA) has a ROA % of 4.11% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tatva Chintan Pharma Chem and its competitors. This is 53% below median its historical median of 8.69. Over the past decade, Tatva Chintan Pharma Chem's ROA % has ranged from 0.69 to 19.71. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #572 out of 1608 companies in the Chemicals industry, placing it in the top 35.6%.
Is Tatva Chintan Pharma Chem's ROA % too high?
Tatva Chintan Pharma Chem's current ROA % of 4.11% is 53% below median its 10-year median of 8.69. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 19.71. The Chemicals industry median ROA % is 2.90. Tatva Chintan Pharma Chem's value of 4.11% is 41.7% above this industry median. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #572 out of 1608 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's ROA % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #572 out of 1608 companies for ROA %. This puts Tatva Chintan Pharma Chem in the upper half of its industry. The industry median ROA % is 2.90. Tatva Chintan Pharma Chem's value of 4.11% is 41.7% above this benchmark. Historically, Tatva Chintan Pharma Chem's own ROA % has ranged from 0.69 to 19.71 over the past decade. While the company's 10-year median is 8.69 vs. the industry median of 2.90, Tatva Chintan Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Chemicals company?
The median ROA % among Chemicals companies is 2.90, based on 1,608 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current ROA % of 4.11% is 41.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tatva Chintan Pharma Chem and its competitors. For the Chemicals industry, the median ROA % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current ROA % is 4.11%, which is 53% below median its own 10-year median of 8.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,464.23, compared to a current price of ₹1,249.60 — trading 14.7% below its estimated fair value. The current ROA % is 4.11%, which is 53% below median its 10-year median of 8.69 and 41.7% above the Chemicals industry median of 2.90. Tatva Chintan Pharma Chem's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current ROA % is 4.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued.
The current stock price of ₹1,249.60 is trading 14.7% below its estimated GF Value™ of ₹1,464.23.
GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Undervalued.
Key valuation signals for NSE:TATVA:
ROA %: 4.11% (53% below median its 10-year median of 8.69)
GF Value™: ₹1,464.23 vs. price of ₹1,249.60 (14.7% below fair value)
Industry Position: 41.7% above the Chemicals median (#572 of 1608)
No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
83GF Score
Get the complete analysis for NSE:TATVA
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TATVA has been successfully added to your 
